Gonyautoxin 2/3 in the Treatment of Acute Back Pain: A Clinical Proof-of-concept Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 11, 2019

Primary Completion Date

March 19, 2020

Study Completion Date

March 19, 2020

Conditions
Back PainAcute Pain
Interventions
DRUG

GTX 2/3

There were 15 patients in this group. Each one received only one treatment.

DRUG

Placebo

There were 15 patients in this group. Each one received only one treatment.

Trial Locations (1)

Unknown

Hospital San José SSMN, Santiago

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Algenis SpA

INDUSTRY